Aidan Ryan
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 4
-
- Trace Elements in Health 3
- Co-authors
- Paul R. Cook (7 shared papers)Sarah J Nevitt (2 shared papers)Orla Tuohy (1 shared paper)Parag P. Sayal (1 shared paper)Elaine Murphy (1 shared paper)Annalisa Sechi (1 shared paper)Douglas Chesher (1 shared paper)Aoife M. Waters (1 shared paper)
- Journals
- The Lancet (3 papers)Journal of Clinical Pathology (3 papers)Cochrane Database of Systematic Reviews (3 papers)BMJ (3 papers)Diabetic Medicine (1 paper)
- Partner nations
- United KingdomIrelandNepal
In The Last Decade
Aidan Ryan
17 papers receiving 1.1k citations
Aidan Ryan's Hit Papers
Peers
Comparison fields: 5 of 86
- Infectious Diseases 708
- Applied Microbiology and Biotechnology 34
- Nephrology 104
- Internal Medicine 27
- Nutrition and Dietetics 79
Countries citing papers authored by Aidan Ryan
This map shows the geographic impact of Aidan Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aidan Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aidan Ryan more than expected).
Fields of papers citing papers by Aidan Ryan
This network shows the impact of papers produced by Aidan Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aidan Ryan. The network helps show where Aidan Ryan may publish in the future.
Co-authors
The 21 scholars most cited alongside Aidan Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | 2021 | 213 | |
| 4 | 2018 | 112 | |
| 5 | 2019 | 58 | |
| 6 | 2016 | 31 | |
| 7 | 2023 | 15 | |
| 8 | 2018 | 9 | |
| 9 | 2015 | 6 | |
| 10 | 2018 | 6 | |
| 11 | 2024 | 6 | |
| 12 | 2018 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2015 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2023 | 1 |
About Aidan Ryan
Aidan Ryan is a scholar working on Infectious Diseases, Nutrition and Dietetics, Clinical Biochemistry, Surgery and Modeling and Simulation, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (5 papers), COVID-19 Clinical Research Studies (4 papers), Trace Elements in Health (3 papers), Metabolism and Genetic Disorders (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Folate and B Vitamins Research (1 paper), Parathyroid Disorders and Treatments (1 paper) and COVID-19 epidemiological studies (1 paper). The work is most often cited by research in Infectious Diseases (708 citations), Applied Microbiology and Biotechnology (34 citations), Nephrology (104 citations), Internal Medicine (27 citations) and Nutrition and Dietetics (79 citations). Aidan Ryan has collaborated with scholars based in United Kingdom, Ireland and Nepal. Frequent co-authors include Paul R. Cook, Sarah J Nevitt, Orla Tuohy, Parag P. Sayal, Elaine Murphy, Annalisa Sechi, Douglas Chesher, Aoife M. Waters, Yehani Wedatilake and Ulpee R. Darbar. Their work appears in journals such as The Lancet, Journal of Clinical Pathology, Cochrane Database of Systematic Reviews, BMJ and Diabetic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.